In shareholder presentations the potential market figures show estimated sufferers and registered sufferers. The registered no is usually less than half the estimated. Now that a treatment is available and the diagnosis is a straightforward blood test ( is it inexpensive?)do we expect the registered numbers to significantly increase?
In shareholder presentations the potential market figures show...
-
- There are more pages in this discussion • 5,780 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.52 |
Change
-0.275(1.99%) |
Mkt cap ! $1.762B | |||
| Open | High | Low | Value | Volume |
| $13.66 | $13.75 | $13.50 | $1.029M | 75.54K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 591 | $13.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.53 | 317 | 12 |
View Market Depth
| Last trade - 10.16am 05/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |